biomea fusion
Edwin Bautista is a seasoned finance professional with extensive experience in accounts payable roles across various companies. Currently serving as a Senior AP Accountant at Biomea Fusion since February 2021, Edwin previously held positions as a Staff Accountant (Accounts Payable) at Tolerion, Inc., and Accounts Payable Specialist at Menlo Therapeutics Inc., Alios BioPharma, Inc., and other organizations. With a career spanning over two decades, Edwin's experience encompasses various aspects of accounts payable management, having worked with companies that have been acquired by major corporations. Edwin holds a B.S. in Accounting from Golden Gate University, obtained in 2016.
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.